Clinical Trial Update: Phoenixin-14 Downregulation in Sepsis

View source ↗

Summary

A completed clinical trial from Firat University assessing downregulation of Phoenixin-14 to reduce mortality in sepsis and evaluating sepsis biomarkers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Phoenixin-14 (Phoenixin-14)

Snippet

Sponsor: Firat University | Conditions: Sepsis - to Reduce Mortality in the Intensive Care Unit, Sepsis Biomarker | Status: COMPLETED